Cargando…
A covalent peptide inhibitor of RGS4 identified in a focused one-bead, one compound library screen
BACKGROUND: Regulators of G protein signaling (RGSs) accelerate GTP hydrolysis by Gα subunits and profoundly inhibit signaling by G protein-coupled receptors (GPCRs). The distinct expression patterns and pathophysiologic regulation of RGS proteins suggest that inhibitors may have therapeutic potenti...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2700083/ https://www.ncbi.nlm.nih.gov/pubmed/19463173 http://dx.doi.org/10.1186/1471-2210-9-9 |
_version_ | 1782168570794344448 |
---|---|
author | Roof, Rebecca A Roman, David L Clements, Samuel T Sobczyk-Kojiro, Katarzyna Blazer, Levi L Ota, Shodai Mosberg, Henry I Neubig, Richard R |
author_facet | Roof, Rebecca A Roman, David L Clements, Samuel T Sobczyk-Kojiro, Katarzyna Blazer, Levi L Ota, Shodai Mosberg, Henry I Neubig, Richard R |
author_sort | Roof, Rebecca A |
collection | PubMed |
description | BACKGROUND: Regulators of G protein signaling (RGSs) accelerate GTP hydrolysis by Gα subunits and profoundly inhibit signaling by G protein-coupled receptors (GPCRs). The distinct expression patterns and pathophysiologic regulation of RGS proteins suggest that inhibitors may have therapeutic potential. We recently described a focused one-bead, one-compound (OBOC) library screen to identify peptide inhibitors of RGS4. Here we extend our observations to include another peptide with a different mechanism of action. RESULTS: Peptide 5nd (Tyr-Trp-c [Cys-Lys-Gly-Leu-Cys]-Lys-NH(2), S-S) blocks the RGS4-Gα(o )interaction with an IC(50 )of 28 μM. It forms a covalent, dithiothreitol (DTT) sensitive adduct with a mass consistent with the incorporation of one peptide per RGS. Peptide 5nd activity is abolished by either changing its disulfide bridge to a methylene dithioether bridge, which cannot form disulfide bridges to the RGS, or by removing all cysteines from the RGS protein. However, no single cysteine in RGS4 is completely necessary or sufficient for 5nd activity. CONCLUSION: Though it has some RGS selectivity, 5nd appears to be a partially random cysteine modifier. These data suggest that it inhibits RGS4 by forming disulfide bridges with the protein. |
format | Text |
id | pubmed-2700083 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-27000832009-06-23 A covalent peptide inhibitor of RGS4 identified in a focused one-bead, one compound library screen Roof, Rebecca A Roman, David L Clements, Samuel T Sobczyk-Kojiro, Katarzyna Blazer, Levi L Ota, Shodai Mosberg, Henry I Neubig, Richard R BMC Pharmacol Research Article BACKGROUND: Regulators of G protein signaling (RGSs) accelerate GTP hydrolysis by Gα subunits and profoundly inhibit signaling by G protein-coupled receptors (GPCRs). The distinct expression patterns and pathophysiologic regulation of RGS proteins suggest that inhibitors may have therapeutic potential. We recently described a focused one-bead, one-compound (OBOC) library screen to identify peptide inhibitors of RGS4. Here we extend our observations to include another peptide with a different mechanism of action. RESULTS: Peptide 5nd (Tyr-Trp-c [Cys-Lys-Gly-Leu-Cys]-Lys-NH(2), S-S) blocks the RGS4-Gα(o )interaction with an IC(50 )of 28 μM. It forms a covalent, dithiothreitol (DTT) sensitive adduct with a mass consistent with the incorporation of one peptide per RGS. Peptide 5nd activity is abolished by either changing its disulfide bridge to a methylene dithioether bridge, which cannot form disulfide bridges to the RGS, or by removing all cysteines from the RGS protein. However, no single cysteine in RGS4 is completely necessary or sufficient for 5nd activity. CONCLUSION: Though it has some RGS selectivity, 5nd appears to be a partially random cysteine modifier. These data suggest that it inhibits RGS4 by forming disulfide bridges with the protein. BioMed Central 2009-05-22 /pmc/articles/PMC2700083/ /pubmed/19463173 http://dx.doi.org/10.1186/1471-2210-9-9 Text en Copyright © 2009 Roof et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Roof, Rebecca A Roman, David L Clements, Samuel T Sobczyk-Kojiro, Katarzyna Blazer, Levi L Ota, Shodai Mosberg, Henry I Neubig, Richard R A covalent peptide inhibitor of RGS4 identified in a focused one-bead, one compound library screen |
title | A covalent peptide inhibitor of RGS4 identified in a focused one-bead, one compound library screen |
title_full | A covalent peptide inhibitor of RGS4 identified in a focused one-bead, one compound library screen |
title_fullStr | A covalent peptide inhibitor of RGS4 identified in a focused one-bead, one compound library screen |
title_full_unstemmed | A covalent peptide inhibitor of RGS4 identified in a focused one-bead, one compound library screen |
title_short | A covalent peptide inhibitor of RGS4 identified in a focused one-bead, one compound library screen |
title_sort | covalent peptide inhibitor of rgs4 identified in a focused one-bead, one compound library screen |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2700083/ https://www.ncbi.nlm.nih.gov/pubmed/19463173 http://dx.doi.org/10.1186/1471-2210-9-9 |
work_keys_str_mv | AT roofrebeccaa acovalentpeptideinhibitorofrgs4identifiedinafocusedonebeadonecompoundlibraryscreen AT romandavidl acovalentpeptideinhibitorofrgs4identifiedinafocusedonebeadonecompoundlibraryscreen AT clementssamuelt acovalentpeptideinhibitorofrgs4identifiedinafocusedonebeadonecompoundlibraryscreen AT sobczykkojirokatarzyna acovalentpeptideinhibitorofrgs4identifiedinafocusedonebeadonecompoundlibraryscreen AT blazerlevil acovalentpeptideinhibitorofrgs4identifiedinafocusedonebeadonecompoundlibraryscreen AT otashodai acovalentpeptideinhibitorofrgs4identifiedinafocusedonebeadonecompoundlibraryscreen AT mosberghenryi acovalentpeptideinhibitorofrgs4identifiedinafocusedonebeadonecompoundlibraryscreen AT neubigrichardr acovalentpeptideinhibitorofrgs4identifiedinafocusedonebeadonecompoundlibraryscreen AT roofrebeccaa covalentpeptideinhibitorofrgs4identifiedinafocusedonebeadonecompoundlibraryscreen AT romandavidl covalentpeptideinhibitorofrgs4identifiedinafocusedonebeadonecompoundlibraryscreen AT clementssamuelt covalentpeptideinhibitorofrgs4identifiedinafocusedonebeadonecompoundlibraryscreen AT sobczykkojirokatarzyna covalentpeptideinhibitorofrgs4identifiedinafocusedonebeadonecompoundlibraryscreen AT blazerlevil covalentpeptideinhibitorofrgs4identifiedinafocusedonebeadonecompoundlibraryscreen AT otashodai covalentpeptideinhibitorofrgs4identifiedinafocusedonebeadonecompoundlibraryscreen AT mosberghenryi covalentpeptideinhibitorofrgs4identifiedinafocusedonebeadonecompoundlibraryscreen AT neubigrichardr covalentpeptideinhibitorofrgs4identifiedinafocusedonebeadonecompoundlibraryscreen |